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Molecular Dynamics Simulations of the GABA Type A Receptor
Timothy Carpenter, Felice Lightstone.
LLNL, Livermore, CA, USA.
The type A GABA-receptors (GABARs) are chloride ion channels found in the
brain and are the major inhibitory neurotransmitter receptors. Upon binding
of an agonist, the GABAR opens and increases the intraneuronal concentration
of chloride ions, thus hyperpolarizing the cell and inhibiting the transmission of
the nerve action potential. GABARs can also be modulated by a variety of phar-
macologically important drugs, such as diazepam and also other regularly
abused drugs such as ethanol. Here, we present homology models (based
upon the 4 A˚ resolution EM acetylcholine receptor structure) and simulations
of the most abundant GABAR subtype (g2a1b2), and also the alcohol-sensitive
subtype (da6b3). As well as GABA itself, a variety of ligands were docked to
the proteins to assess the potential binding sites, and also the affect of ligand
binding on the properties of the structure. Through the modeling and simulation
of the two different receptor subtypes, and comparison of the ligand effects
upon each one, we are able to gain greater insight into the specific residues im-
portant in binding, and also details of the different behavior of the subtypes.
This work performed under the auspices of the U.S. Department of Energy
by Lawrence Livermore National Laboratory under Contract DE-AC52-
07NA27344. Release number LLNL-ABS-417208.
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An Electrophysiology Assay for the Fast Characterization of GABAA Ion
Channel Modulators
Qin Chen, Ian Spencer, Juliette Johnson, Cristian Ionescu-Zanetti.
Fluxion Biosciences, South San Francisco, CA, USA.
The GABAA receptors belong to a family of ligand-gated ion channels mediat-
ing fast synaptic transmission. They are drawing great attention in the pharma-
ceutical industry due to their potential role in the development of new therapeu-
tics affecting anxiety, sleep disorders, and muscle relaxation. However, ligand-
gated ion channel screening has been hampered by the lack of suitable high
throughput electrophysiology platforms. The existing electrophysiology
screening platform (IonWorks) is unable to apply ligands rapidly during current
recording, which can be a major drawback for inactivating channels. While
some studies have shown that it is possible to record the GABA tail current
and use that information during a screen, such methods have an inherently
lower signal to noise ratio and cannot be used on faster desensitizers.
Here we present the use of a novel electrophysiology screening platform inte-
grating a microfluidics network for the study of GABAA receptor pharmacol-
ogy. This platform features fast (<100ms) solution exchange coupled with si-
multaneous data recording. A novel assay could monitor GABA response in
real time, and obtain a 3 point EC50 dose curve within 1 minute.
The GABAA a1b3g2 expressing HEK cells from Millipore were used for this
study. The channel was targeted with agonists, including GABA and muscimol,
inhibitors (picrotoxin, bicuculline, and gabazine), and positive modulators, includ-
ing diazepam, zolpidem and chlordiazepoxide. The positive modulators produced
concentration dependent augmentation of the GABA EC20 response. The pharma-
cology data determined using this method was consistent with the literature values
obtained using other platforms. Statistical data for inter and intra-plate reproduc-
ibility, current stability, and Z-values, is used to validate this approach.
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Characterization of the Etomidate Binding Site in Expressed a1b3
GABAAR by Photoaffinity Labeling
David C. Chiara1, Zuzana Dostalova2, Aiping Liu2, Xiaojuan Zhou2,
Stuart A. Forman2, Keith W. Miller2, Jonathan B. Cohen1.
1Harvard Medical School, Boston, MA, USA, 2Massachusetts General
Hospital, Boston, MA, USA.
A major site of general anesthetic action is the inhibitory g-aminobutyric acid
type A receptor (GABAAR), which responds to various anesthetics by an en-
hanced GABA response. Using a photoreactive analog of the general anesthetic
etomidate ([3H]azietomidate), the etomidate binding site in the bovine brain GA-
BAAR was identified by the pharmacologically specific photolabeling of two
amino acids in the transmembrane domain, bMet-286 in the M3 helix and
aMet-236 (a1 numbering) in the M1 helix, which both project into the interface
between the b and a subunits (Li et al, J. Neurosci., 2006 26:11599-605). The
GABAAR preparation used in that study was heterogeneous, as it was isolated
on a benzodiazepine affinity column from a detergent extract of brainmembranes.
To examine anesthetic interactions with GABAAR of known subunit composi-
tion, we expressed a1b3 GABAAR in HEK cells with an N-terminal FLAG epi-
tope tag on a1 and purified hundreds of picomoles of receptor by detergent
solubilization, affinity chromatography, and reconstitution into lipid. When this
GABAAR was photolabeled with [
3H]azietomidate, the 3H incorporation wasenhanced by GABA and inhibited by etomidate, as determined by SDS-PAGE.
From a preparative scale [3H]azietomidate photolabeling of GABAAR (350
pmol of muscimol binding sites), potential photoincorporation in each of the 4
transmembrane helices from both the a1 and b3 subunits was examined by Ed-
man degradation. In the a1b3 GABAAR, [
3H]azietomidate photolabeled the
two residues at the b-a interface identified previously, as well as three additional
residues, two within the b3M3 helix and the third in the a1M3 helix. To deter-
mine if these new labeled residues contribute to an etomidate binding site or rep-
resent lipid-exposed labeling, we are currently characterizing the etomidate inhi-
bition of [3H]azietomidate photolabeling at the level of individual amino acids.
3666-Pos
Effect of GABA Concentration on Current-Voltage Properties of the
GABA(A) Receptor
Kate O’Toole, Andrew Jenkins.
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The g-aminobutyric acid type A (GABAA) receptor functions as a chemical to
voltage transducer in the central nervous system, converting neurotransmitter
signals to changes in postsynaptic membrane potential. The kinetics of GA-
BAergic currents are known to be affected by membrane potential, but the de-
pendence on neurotransmitter concentration has not been fully explored. The
present study investigates the current-voltage (IV) relationship of a1b2g2s
GABAA receptors across a range of GABA concentrations using whole-cell
patch clamp of transfected HEK293 cells. We have determined and validated
a voltage ramp protocol verses a more traditional stepwise procedure, in order
to rapidly quantify rectification, hysteresis and the reversal potential at GABA
concentrations ranging from 0.3 to 1000 mM. Results show that the rectification
and hysteresis of the IV curves are dependent on GABA concentration, whereas
the reversal potential is independent. Specifically, measures of rectification and
hysteresis segregated into two distinct populations, at low (0.3-10 mM) and high
(30-1000 mM) GABA concentrations. We provide evidence that the current-
voltage properties of GABAA receptors are concentration dependent and, con-
sequently, that the GABA concentration must be taken into context when de-
signing experiments and interpreting results. Finally, these results have impli-
cations for a better understanding of synaptic responses where receptor location
plays a role in the level of GABA exposure.
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Mirko Moroni, Marco Beato, Lucia G. Sivilotti.
University College London, London, United Kingdom.
GABA-A and glycine receptors are ligand-gated ion channels belonging to the
Cys-loop superfamily. They are permeable to anions and mediate fast synaptic
inhibition in the central nervous system. We recently showed that intracellular
chloride can affect the time course of deactivation of these channels (1). The
aim of the present work was to identify the residues that are involved in ‘‘sens-
ing’’ the intracellular chloride concentration.
We used the fast concentration jump technique to apply brief pulses (1-3 ms) of
saturating glycine or GABA to outside-out patches from transiently-transfected
HEK cells expressing alpha1 or alpha1 beta glycine receptors or alpha1 beta2
gamma2L GABA-A receptors. The effect of intracellular chloride could be me-
diated either by residues in intracellular loops, such as M1-M2 and M3-M4, or
by the residues lining the channel itself. We used a combination of deletion and
Ala/Cys-scanning mutagenesis approaches to address this question.
In other nicotinic channels, the long M3-M4 intracellular loop can be replaced by
the equivalent domain (7 amino acids) of the orthologous prokaryotic channel
from Gloeobacter violaceus without losing channel function (2). We found that
chimeric constructs of glycine and GABA-A receptors containing the prokaryotic
M3-M4 domain retained modulation by intracellular chloride, suggesting that the
major cytoplasmic domain is unlikely to mediate this effect. The results of muta-
genesis of residues facing the ion permeation pathway on the contrary strongly
suggests that chloride ions affect channel kinetic by binding to a site along the
pore; we have identified conserved residues that reduce the differences between
the deactivation rates measured at different chloride concentrations.
(1) Pitt, Sivilotti and Beato (2008) J.Neurosci 28, 11454-11467
(2) Jansen, Bali and Akabas (2008) J.Gen.Physiol. 131, 137-146
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